Industry analyst GlobalData has highlighted research showing the potential of Janssen’s Tremfya (guselkumab) in the treatment of psoriasis. 30 May 2023
Positive Phase III results for Sanofi’s trailblazing biologic Dupixent (dupilumab) could open up a significant opportunity in a new treatment setting. 22 May 2023
UK-based Senisca, a biotech company developing RNA-based therapeutics to reverse cellular senescence and target age-related disease, has announced an expansion 18 May 2023
Spanish dermatology company Almirall has recorded net sales of 230 million euros ($253 million) in the first quarter, a 6% increase, and net income of 7.7 milli 9 May 2023
Regeneron was trading 7% lower on Thursday lunchtime following the presentation of its first-quarter financial results and latest guidance for 2023. 4 May 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.